David McKillop

678 total citations
11 papers, 353 citations indexed

About

David McKillop is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David McKillop has authored 11 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David McKillop's work include Drug Transport and Resistance Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). David McKillop is often cited by papers focused on Drug Transport and Resistance Mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). David McKillop collaborates with scholars based in United Kingdom, India and Singapore. David McKillop's co-authors include Joanna Leadbetter, Malcolm Ranson, Martin Wild, Helen Swaisland, Robert P. Smith, H. F. Bradford, Sharon Barnett, John Kemp, T C Stephens and E. A. Partridge and has published in prestigious journals such as Biochemical Pharmacology, Clinical Pharmacokinetics and Molecular Cancer Therapeutics.

In The Last Decade

David McKillop

10 papers receiving 337 citations

Peers

Countries citing papers authored by David McKillop

Since Specialization

Citations

This map shows the geographic impact of David McKillop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McKillop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McKillop more than expected).

Fields of papers citing papers by David McKillop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McKillop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McKillop. The network helps show where David McKillop may publish in the future.

Co-authorship network of co-authors of David McKillop

This figure shows the co-authorship network connecting the top 25 collaborators of David McKillop. A scholar is included among the top collaborators of David McKillop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David McKillop. David McKillop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol 2005 ·Clinical Pharmacokinetics ·Helen Swaisland, Malcolm Ranson, Robert P. Smith, Joanna Leadbetter, (unknown), David McKillop, Martin Wild	132
2	Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor 2005 ·Molecular Cancer Therapeutics ·David McKillop, E. A. Partridge, John Kemp, (unknown), Jane Kendrew, Sharon Barnett, (unknown), (unknown), (unknown), Francis Bichat, Nicolas Guilbaud, T C Stephens	109
3	Antioxidant status of oral mucosal tissue and plama levels in smokers and non‐smokers 1999 ·Journal of Oral Pathology and Medicine ·C G Cowan, (unknown), Ian Young, David McKillop, P.‐J. Lamey	12
4	Absence of hepatic enzyme induction in prostate cancer patients receiving `Casodex' (bicalutamide) 1996 ·Anti-Cancer Drugs ·Amir Kaisary, Peter Klarskov, David McKillop	10
5	Different inhibition and induction profiles of hepatic drug metabolism in rats and dogs by two structurally related pyridyl diazinone cardiotonic agents 1991 ·Biochemical Pharmacology ·David McKillop, Kathryn Pickup	1
6	Mutagenicity, carcinogenicity and toxicity of β-naphthoflavone, a potent inducer of P448 1991 ·Biochemical Pharmacology ·David McKillop, (unknown)	35
7	Effects of phenobarbitone and β-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog 1985 ·Biochemical Pharmacology ·David McKillop	19
8	Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes 1981 ·Biochemical Pharmacology ·David McKillop, H. F. Bradford	18
9	Microsomal Biphenyl Hydroxylation: The Effect of Selective Deuterium Substitution on the Rate of Formation of the Monohydroxybiphenyls 1979 ·Biochemical Society Transactions ·James Winfred Bridges, David McKillop, Peter J. Cox, Peter B. Farmer, A. B. Foster, Michael Jarman	1
10	Nadh synergism of microsomal aniline metabolism in the presence of enhancing agents 1977 ·Biochemical Pharmacology ·Garth Powis, (unknown), David McKillop	15
11	The Metabolism and Binding of Catecholamines by the Hepatic Microsomal Fraction of the Rat 1976 ·Biochemical Society Transactions ·David McKillop, Garth Powis	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact